2022 - - 20

MMWR Booster for: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022, Weekly / December 30, 2022 / 71(5152);1616–1624

Posted on January 3, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: Bivalent mRNA Vaccine Effectiveness: The study found that bivalent mRNA vaccines are effective in preventing COVID-19–associated emergency department/urgent care encounters and hospitalizations among immunocompetent adults. Comparative Analysis:

MMWR Booster for: Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons — 29 U.S. Jurisdictions, May 22–September 3, 2022, Weekly / December 30, 2022 / 71(5152);1610–1615

Posted on January 2, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: One-Dose JYNNEOS Vaccine Efficacy: One dose of JYNNEOS vaccine, administered ≥14 days before illness onset, demonstrated some protective effects against mpox, including reduced symptoms and lower hospitalization

MMWR Booster for: Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults — United States, May–November 2022, December 30, 2022 / 71(5152);1605–1609

Posted on January 1, 2024 by Cody Micah Carmichael MPH, CPH

In this entry of MMWR Booster, a summary is provided about findings regarding Clinical and Epidemiological Data in regards to Mpox in Gender Diverse Persons.

Epidemiology, Broadly Speaking

Tag: 2022